TRANE-TECHNOLOGIES
16.11.2021 09:32:06 CET | Business Wire | Press release
Thermo King® , the transport refrigeration brand of global climate innovator Trane Technologies (NYSE: TT), today premiered its trailer refrigeration system with zero direct carbon emissions at the Solutrans international trade show in Lyon, France.
The Thermo King® AxlePower technology combines a fully electric refrigeration unit, highly efficient battery storage, and the ability to run on low or zero-emissions power sources, such as an axle energy recovery system, shore power or hybrid system. The sustainable battery enables the refrigeration unit to operate autonomously and keep the cargo at optimal temperature, even when the vehicle is not running.
“Safe, sustainable transport of foods, medicines and vaccines is more critical than ever,” said Francesco Incalza, president of Thermo King Europe, Middle East, and Africa. “Temperature-controlled transport is subject to the highest operational safety requirements. Our technology can ensure sensitive goods stay at the required temperature, while reducing energy, emissions, and noise – all important to a sustainable future. We’re proud to continue to deliver breakthrough technology, which supports our customers’ sustainability goals and our Gigaton Challenge to reduce customer carbon emissions by one gigaton by 2030.”
The new solution delivers immediate and long-term sustainability benefits while reducing operating costs. With zero direct emissions and silent operation, it enables inner-city deliveries, including in Ultra-low Emission Zones (ULEZs). Intelligent energy management ensures that there are always enough battery reserves, even on long journeys or in traffic jams. If necessary, the system can also harvest energy from the tractive power of the trailer. All components are monitored in real time by a Thermo King telematics system.
Thermo King will showcase the AxlePower zero-direct emission trailer refrigeration unit powered by BPW’s ePower system at the Solutrans international trade show , Nov. 16-20. Currently in the testing phase, this integrated system recovers energy generated when the vehicle is rolling, sailing or braking and stores it in Thermo King’s efficient battery to power the refrigeration system. This system is tractor-independent and compatible with all Thermo King trailer refrigeration units. The solution has been nominated from more than 100 applications as one of seven finalists for the Solutrans Innovation Award.
Also showcased at the event will be Thermo King’s E200 fully electric unit for small vans and trucks, and the new Advancer Hybrid refrigeration unit, the latest addition to the Advancer A-Series trailer range, which seamlessly switches between the primary electric operating mode to engine power when needed.
“At Trane Technologies, sustainability is at the centre of everything we do as we challenge what’s possible for the industry, and the world,” said Incalza. “For decades, Thermo King has led the industry in electrification of transport refrigeration, and we continue to relentlessly innovate in support of our customers, our communities and our planet.”
Thermo King has committed to invest more than $100 million over the next three years to deliver a fully-electric product in every segment of the cold chain by 2023 in EMEA and 2025 in the Americas.
With its 2030 Sustainability Commitments , Trane Technologies is helping solve for some of the world’s biggest sustainability challenges. These commitments include a pledge to reduce customer greenhouse gas emissions by one gigaton (2% of the world’s annual emissions) and achieve carbon-neutral operations. Its “Opportunity for All” pledge commits to achieving gender parity in leadership, workforce diversity reflective of its communities, and community initiatives that support equitable education and pathways to green and Science, Technology, Engineering and Math (STEM) careers.
About Thermo King
Thermo King – by Trane Technologies (NYSE: TT), a global climate innovator – is a worldwide leader in sustainable transport temperature control solutions. Thermo King has been providing transport temperature control solutions for a variety of applications, including trailers, truck bodies, buses, air, shipboard containers, and railway cars since 1938. For more information, visit www.thermoking.com
or www.europe.thermoking.com
.
About Trane Technologies
Trane Technologies is a global climate innovator. Through our strategic brands Trane® and Thermo King®, and our environmentally responsible portfolio of products and services, we bring efficient and sustainable climate solutions to buildings, homes, and transportation. Learn more at tranetechologies.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005093/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 10:00:00 CEST | Press release
Gabriele Salvatores, together with Rob Minkoff, Catherine Hardwicke, Jed Weintrob, Christina Lee Storm, Nils Hartmann, Guillem Martinez Roura, Filippo Rizzante, Giacomo Mineo, Brian Welk and Denise Negri, will judge the short films in competition based on creativity, production quality and the use of Artificial Intelligence. Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, wh
Bregal Milestone Announces Majority Growth Investment in CoreGo, a Leading European Open-Loop Payment and Event Technology Company29.4.2026 10:00:00 CEST | Press release
Investment follows over 98% annual growth and supports CoreGo’s continued market expansion Bregal Milestone, a leading European software growth private equity firm, today announced a majority strategic growth investment in CoreGo Oy ("CoreGo" or the "Company"), a leading provider of open-loop payments and integrated technology solutions for festivals, sports events, and venues across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427991105/en/ Founded in Helsinki in 2015 by Hannu Elomaa and CTO Nikoteemu Väänänen, CoreGo has built one of Europe's most differentiated open-loop payment infrastructure and event technology businesses. Serving approximately 250 customers across the Nordics and DACH region, the Company delivers an integrated showtime-critical suite of solutions through CoreGo Cloud, unifying payments, access, networks, and data into a single real-time operating system. CoreGo’s in-house private network
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom